Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Lenalidomide

2

XIX.a BAL: An excess proportion of lymphocytes

1
Last update : 05/03/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Pomalidomide
1
Thalidomide
2

Publications

Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients.
European respiratory review : an official journal of the European Respiratory Society 2013 Mar 01;22;93-5 2013 Mar 01
Drug-induced interstitial pneumonitis due to low-dose lenalidomide.
Internal medicine (Tokyo, Japan) 2012;51;1081-5 2012
Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.
Chest 2007 May;131;1572-4 2007 May

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies